IRadimed Q3 revenue beats estimates, narrows guidance
IRMD•IRadimed reported third-quarter revenue of $24.20 million, up 14% year over year and above the $23.47 million consensus estimate. It narrowed its 2026 outlook, forecasting revenue of $91.6 million to $93.1 million and GAAP diluted EPS of $1.90 to $1.94.
1. Quarterly results
Third-quarter non-GAAP diluted EPS rose 17% year over year to $0.55. The company’s reported Q3 EPS was $0.51.
2. Updated outlook
IRadimed expects fourth-quarter revenue of $25.0 million to $26.5 million. It lowered its full-year 2026 revenue outlook to $91.6 million to $93.1 million and its GAAP diluted EPS forecast to $1.90 to $1.94.
3. Bookings and products
The company said Q3 revenue growth was driven by the continued launch of its 3870 MR IV pump. Quarterly bookings set a record, supported by higher monitor unit sales and a 45% year-over-year increase in domestic pump channels; over 70% of pump bookings were for the “quad stack” configuration.
